| P2093 | author name string | Bejarano PF | |
| P2860 | cites work | Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing | Q24563789 |
| | Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 |
| | Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions | Q33659127 |
| | Effects of nonsteroidal anti-inflammatory therapy on platelets | Q33676724 |
| | The clinical potential of cyclooxygenase-2-specific inhibitors | Q33676740 |
| | Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee | Q34118775 |
| | Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice | Q34262516 |
| | TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue | Q34584790 |
| | An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants. | Q34712405 |
| | The role of non-steroidal anti-inflammatory drugs in acute liver injury | Q35823464 |
| | n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis | Q36888170 |
| | Prostaglandin endoperoxide synthase: regulation of enzyme expression | Q37335647 |
| | Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model | Q39440579 |
| | Meloxicam: Selective COX-2 inhibition in clinical practice | Q39455254 |
| | Nonsteroidal anti-inflammatory drugs: gastropathy, deaths, and medical practice | Q39516885 |
| | A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization | Q40394251 |
| | Spinal Cord Effects of Antipyretic Analgesics | Q40394256 |
| | The Spinal Actions of Nonsteroidal Anti-Inflammatory Drugs and the Dissociation between their Anti-Inflammatory and Analgesic Effects | Q40394262 |
| | New insights into the mode of action of anti-inflammatory drugs | Q40476391 |
| | Rheumatoid arthritis and osteoarthritis: current and future therapies | Q40586552 |
| | Non-steroidal anti-inflammatory drugs and spinal nociceptive processing | Q40591639 |
| | NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System. | Q40858702 |
| | Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection | Q40949566 |
| | Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs | Q41355113 |
| | A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein | Q41653311 |
| | The relative toxicity of disease-modifying antirheumatic drugs | Q41938212 |
| | The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes | Q42098787 |
| | Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat | Q43453302 |
| | Anatomical mapping of brain sites involved in the antinociceptive effects of ketoprofen | Q44884917 |
| | Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 |
| | Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity | Q47899971 |
| | Nimesulide and renal impairment. | Q50647615 |
| | Multiple female reproductive failures in cyclooxygenase 2-deficient mice. | Q52527670 |
| | Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. | Q53437653 |
| | Towards a mechanism-based classification of pain? | Q54118589 |
| | Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs | Q57945428 |
| | Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis | Q68984175 |
| | An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment | Q71078951 |
| | Trends in hospital admissions and death rates for peptic ulcer in the United States from 1970 to 1978 | Q71127757 |
| | A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis | Q72718482 |
| | A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen | Q73113389 |
| | Safety of meloxicam: a global analysis of clinical trials [British Journal of Rheumatology, 1996;35(suppl. 1):68-77] | Q73582854 |
| | Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs | Q74097807 |
| | Cyclooxygenase-2 in the spinal cord: localization and regulation after a peripheral inflammatory stimulus | Q74483726 |
| | Hepatotoxicity of non-narcotic analgesics | Q77142017 |
| | Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects | Q77341378 |
| | Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids | Q77362689 |
| | The classification of cyclooxygenase inhibitors | Q77701962 |
| | Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen | Q77927267 |
| | COX-2 inhibitors | Q77937806 |
| P433 | issue | 6 | |
| P921 | main subject | pain management | Q621261 |
| P304 | page(s) | 432-439 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Current review of pain | Q27714717 |
| P1476 | title | Management of Inflammatory Pain with Selective COX-2 Inhibitors: Promises and Facts | |
| P478 | volume | 3 | |